Genfit

Genfit EBITDA per Share

The EBITDA per Share of Genfit (GNFT.PA) as of Oct 12, 2026 is -1.21 EUR. In the previous year, EBITDA per Share was 0.10 EUR — a change of -1,294.36% (lower).

EBITDA per Share

-1.21EUR

YoY

-1,294.36%

Last updated:

EBITDA per Share of Genfit is 2025 -1.21 EUR. EBITDA per Share of Genfit was 2024 0.10 EUR. It decreases by -1,294.36% lower compared to the previous year.

The Genfit EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-2.18 EUR
Jan 1, 2019
-1.34 EUR
Jan 1, 2020
-2.10 EUR
Jan 1, 2021
0.61 EUR
Jan 1, 2022
-0.52 EUR
Jan 1, 2023
-0.51 EUR
Jan 1, 2024
0.10 EUR
Jan 1, 2025
-1.21 EUR
The Genfit EBITDA per Share history
YEAREBITDA per ShareYoY
-1.21EUR-1,294.36%
0.10EUR-119.72%
-0.51EUR-2.34%
-0.52EUR-186.56%
0.61EUR-128.93%
-2.10EUR+56.54%
-1.34EUR-38.45%
-2.18EUR+21.60%
-1.79EUR+50.73%
-1.19EUR+65.63%
-0.72EUR-1.43%
-0.73EUR—
Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

EBITDA per Share of Genfit is -1.21 EUR in 2025.

EBITDA per Share of Genfit changed from 0.10 EUR to -1.21 EUR, representing a -1,294.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Genfit since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Genfit

All Key Metrics — Genfit